Hydroxychloroquine Market
Hydroxychloroquine - Global Market Outlook (2018-2027)
According to Stratistics MRC, the Global Hydroxychloroquine Market is accounted for $41.30 million in 2018 and is expected to reach $100.62 million by 2027 growing at a CAGR of 10.4% during the forecast period. The rising geriatric population, and the high demand for the drug from third world nations for dealing with malarial are the major factors propelling the market growth. However, factors such as product recalls and discontinuation of drugs are hampering the market growth.
Hydroxychloroquine is a medication and analogue of chloroquine. It has antirheumatic as well as antimalarial properties. It has been used widely for the treatment of infectious as well as rheumatoid arthritis. It has been recognized that clinical use of hydroxychloroquine has significantly improve the treatment rate of patient suffering from the COVID-19. The growth of hydroxychloroquine enhanced by the growing cases of infectious diseases that majorly includes coronavirus and malaria and increase research and development activities. In addition, advances in the treatment options and presence of well-established healthcare facilities are some of the impacting factors for the demand of hydroxychloroquine drugs.
Based on the application, the COVID-19 segment is going to have a lucrative growth during the forecast period as this is a new condition and a large number of trials are conducted on the effectiveness of the medicine in treating the condition, it would contribute to the growth rate witnessed by this segment. The fact that a large number of patients with COVID-19 are admitted to hospitals for treatment results in high preference and dependence on this medicine, contributing to the market share held by this segment.
By geography, Asia Pacific is going to have a lucrative growth during the forecast period attributed to India being the leading producer of the drug and China being the largest exporter of the raw materials for the drug production. Apart from this, it is cost-effective drug in India costing nearly lesser than rupees three per tablet. Moreover, the drug has been advocated in countries like India as a measure to prevent the coronavirus in people who have been in contact with COVID positive persons and those falling in high risk zone. All these aforementioned aspects are likely to favorably leverage the growth of the Hydroxychloroquine market over the forecast period.
Some of the key players profiled in the Hydroxychloroquine Market include Hikma Pharmaceuticals PLC, Cadila Healthcare Ltd, Ipca Laboratories Ltd, Novartis AG , Mylan N.V, Sanofi S.A, Taj Pharmaceuticals Ltd , Shanghai Pharmaceuticals Holding Co., Ltd, Torrent Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd , Dr. Reddy’s Laboratories Ltd, Sun Pharmaceutical Industries Ltd, and Zydus Cadila.
Types Covered:
• Tablets
• Injection
Route of Administrations Covered:
• Oral
• Intravenous
Grades Covered:
• United States Pharmacopeial Convention (USP) Standards Grade
• Pharmaceutical Standards Grade
• European Pharmacopoeia (EP) Standards Grade
Strengths Covered:
• 100 mg
• 200 mg
• 250 mg
• 400 mg
• 500 mg
• 800 mg
Distribution Channels Covered:
• Hospital Pharmacy
• Online Pharmacy
• Speciality Drug Stores
• Retail Pharmacy
• Homeocare
Applications Covered:
• Malaria
• Rheumatoid arthritis
• Lupus Erythematosus
• Skin Lesions
• COVID-19
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Hydroxychloroquine Market, By Type
5.1 Introduction
5.2 Tablets
5.3 Injection
6 Global Hydroxychloroquine Market, By Route of Administration
6.1 Introduction
6.2 Oral
6.3 Intravenous
7 Global Hydroxychloroquine Market, By Grade
7.1 Introduction
7.2 United States Pharmacopeial Convention (USP) Standards Grade
7.3 Pharmaceutical Standards Grade
7.4 European Pharmacopoeia (EP) Standards Grade
8 Global Hydroxychloroquine Market, By Strength
8.1 Introduction
8.2 100 mg
8.3 200 mg
8.4 250 mg
8.5 400 mg
8.6 500 mg
8.7 800 mg
9 Global Hydroxychloroquine Market, By Distribution Channel
9.1 Introduction
9.2 Hospital Pharmacy
9.3 Online Pharmacy
9.4 Speciality Drug Stores
9.5 Retail Pharmacy
9.6 Homeocare
10 Global Hydroxychloroquine Market, By Application
10.1 Introduction
10.2 Malaria
10.3 Rheumatoid arthritis
10.4 Lupus Erythematosus
10.4.1 Systemic Lupus Erythematosus
10.4.2 Chronic Discoid Lupus Erythematosus
10.5 Skin Lesions
10.6 COVID-19
11 Global Hydroxychloroquine Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Hikma Pharmaceuticals PLC
13.2 Cadila Healthcare Ltd
13.3 Ipca Laboratories Ltd
13.4 Novartis AG
13.5 Mylan N.V
13.6 Sanofi S.A
13.7 Taj Pharmaceuticals Ltd
13.8 Shanghai Pharmaceuticals Holding Co., Ltd
13.9 Torrent Pharmaceuticals Ltd
13.10 Teva Pharmaceutical Industries Ltd
13.11 Dr. Reddy’s Laboratories Ltd
13.12 Sun Pharmaceutical Industries Ltd
13.13 Zydus Cadila
List of Tables
1 Global Hydroxychloroquine Market Outlook, By Region (2017-2027) ($MN)
2 Global Hydroxychloroquine Market Outlook, By Type (2017-2027) ($MN)
3 Global Hydroxychloroquine Market Outlook, By Tablets (2017-2027) ($MN)
4 Global Hydroxychloroquine Market Outlook, By Injection (2017-2027) ($MN)
5 Global Hydroxychloroquine Market Outlook, By Route of Administration (2017-2027) ($MN)
6 Global Hydroxychloroquine Market Outlook, By Oral (2017-2027) ($MN)
7 Global Hydroxychloroquine Market Outlook, By Intravenous (2017-2027) ($MN)
8 Global Hydroxychloroquine Market Outlook, By Grade (2017-2027) ($MN)
9 Global Hydroxychloroquine Market Outlook, By United States Pharmacopeial Convention (USP) Standards Grade (2017-2027) ($MN)
10 Global Hydroxychloroquine Market Outlook, By Pharmaceutical Standards Grade (2017-2027) ($MN)
11 Global Hydroxychloroquine Market Outlook, By European Pharmacopoeia (EP) Standards Grade (2017-2027) ($MN)
12 Global Hydroxychloroquine Market Outlook, By Strength (2017-2027) ($MN)
13 Global Hydroxychloroquine Market Outlook, By 100 mg (2017-2027) ($MN)
14 Global Hydroxychloroquine Market Outlook, By 200 mg (2017-2027) ($MN)
15 Global Hydroxychloroquine Market Outlook, By 250 mg (2017-2027) ($MN)
16 Global Hydroxychloroquine Market Outlook, By 400 mg (2017-2027) ($MN)
17 Global Hydroxychloroquine Market Outlook, By 500 mg (2017-2027) ($MN)
18 Global Hydroxychloroquine Market Outlook, By 800 mg (2017-2027) ($MN)
19 Global Hydroxychloroquine Market Outlook, By Distribution Channel (2017-2027) ($MN)
20 Global Hydroxychloroquine Market Outlook, By Hospital Pharmacy (2017-2027) ($MN)
21 Global Hydroxychloroquine Market Outlook, By Online Pharmacy (2017-2027) ($MN)
22 Global Hydroxychloroquine Market Outlook, By Speciality Drug Stores (2017-2027) ($MN)
23 Global Hydroxychloroquine Market Outlook, By Retail Pharmacy (2017-2027) ($MN)
24 Global Hydroxychloroquine Market Outlook, By Homeocare (2017-2027) ($MN)
25 Global Hydroxychloroquine Market Outlook, By Application (2017-2027) ($MN)
26 Global Hydroxychloroquine Market Outlook, By Malaria (2017-2027) ($MN)
27 Global Hydroxychloroquine Market Outlook, By Rheumatoid arthritis (2017-2027) ($MN)
28 Global Hydroxychloroquine Market Outlook, By Lupus Erythematosus (2017-2027) ($MN)
29 Global Hydroxychloroquine Market Outlook, By Systemic Lupus Erythematosus (2017-2027) ($MN)
30 Global Hydroxychloroquine Market Outlook, By Chronic Discoid Lupus Erythematosus (2017-2027) ($MN)
31 Global Hydroxychloroquine Market Outlook, By Skin Lesions (2017-2027) ($MN)
32 Global Hydroxychloroquine Market Outlook, By COVID-19 (2017-2027) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
